Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report

The present study aimed to evaluate the therapeutic efficacy of dasatinib in a patient with nucleoporin 214-tyrosine protein kinase ABL1 proto-oncogene 1 (NUP214-ABL1)-positive early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL), as well as that of selinexor and dasatinib for NUP214-ABL1-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Zhang, Li, Huang, Jiankun, Hong, Xiuli, Zhao, Jiangning, Wang, Zhao, Zhang, Kejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647690/
https://www.ncbi.nlm.nih.gov/pubmed/29067094
http://dx.doi.org/10.3892/etm.2017.5046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647690/
https://www.ncbi.nlm.nih.gov/pubmed/29067094
http://dx.doi.org/10.3892/etm.2017.5046

Ejemplares similares